Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient’s Activity Level

BACKGROUND: Livedoid vasculopathy (LV) is a rare disease characterized by livedo racemosa, atrophie blanche, ulcerations, and severe pain. Low molecular weight heparins and rivaroxaban can be used in LV-patients. In addition, intravenous immunoglobulins (IVIG) have been described as treatment-option...

Descripción completa

Detalles Bibliográficos
Autores principales: Kofler, Katrin, Strölin, Anke, Geiger, Vanessa, Kofler, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474298/
https://www.ncbi.nlm.nih.gov/pubmed/33779349
http://dx.doi.org/10.1177/12034754211003525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474298/
https://www.ncbi.nlm.nih.gov/pubmed/33779349
http://dx.doi.org/10.1177/12034754211003525

Ejemplares similares